|Industry||Medical devices, Medical technology|
|Founded||San Antonio, Texas, 1976|
|Headquarters||San Antonio, Texas, United States|
|James R. Leininger (founder), Joseph F. Woody, President and CEO|
|Products||Items related to negative pressure wound therapy and wound healing|
|Revenue||$1.6 billion (2010)|
|$256.1 million (2010)|
Number of employees
|Slogan||The Clinical Advantage|
Kinetic Concepts, Inc., (KCI) is a global corporation that produces medical technology related to wounds and wound healing. KCI produced the first product developed specifically for negative pressure wound therapy. As of 2013[update] the company employs 5,000 people and markets its products in more than 25 countries. Its headquarters is in San Antonio, Texas. Currently, KCI, LifeCell and Systagenix operate under one global medical technology brand known as Acelity.
The KCI Negative Pressure platform uses negative pressure technology to provide physicians with clinically proven therapies, to treat a broad spectrum of hard-to-heal wounds, e.g., traumatic wounds, pressure ulcers, chronic wounds, diabetic and venous stasis ulcers, surgical incisions and open abdomen management. It is also used to protect surgical incisions that are at risk of infection.
Vacuum Assisted Closure (V.A.C.) Therapy delivers negative pressure (a vacuum) to the wound site to create an environment that promotes wound healing by helping to:
- draw wound edges together.
- remove infectious materials.
- promote granulation tissue formation.
KCI was founded in 1976 in San Antonio, Texas, by James R. Leininger, then an emergency room physician who wanted to help prevent the pulmonary complications associated with immobility. Over time, the company developed or acquired a line of therapeutic specialty beds, introducing a specialty bed for acute care patients with pulmonary complications. Initially KCI's product development focused on therapeutic beds and surfaces then expanded to introduce the first commercial negative pressure wound therapy products in the mid-1990s. KCI acquired regenerative medicine company, LifeCell, in 2008  in a non-hostile transaction for US$1.7 billion. In January 2012, LifeCell was made a sister company to KCI.
From the founding of the company in 1976 to 1988, the revenue of KCI grew to US$153.2 million. The growth in revenue allowed KCI to go public and trade on the New York Stock Exchange (NYSE) in 1988. KCI stock was traded on the NYSE until 1997, when the company went private. In February 2004, KCI became a publicly listed company for the second time and was listed on the NYSE under the ticker symbol KCI. By the late 2000s the company's revenue was over $1 billion and reported an increase of 17 percent in 2007 to $1.61 billion. Revenue for 2008 was $1.88 billion, increasing to $1.99 billion in 2009 and in 2010 increased to $2.02 billion. On November 4, 2011, the company went private again at a price of $68.50 per share. KCI is owned by a consortium consisting of Apax Partners and controlled affiliates of the Canada Pension Plan Investment Board and Public Sector Pension Investment Board.
- V.A.C. systems used for negative pressure wound therapy.
- "Products". KCI1.com. Retrieved 17 March 2011.
- "FDA clears new KCI abdominal wound-care product". San Antonio Business Journal. 19 May 2009. Retrieved 25 January 2011.
- Apelqvist J, Armstrong DG, Lavery LA, et al. Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds. The American Journal of Surgery 2008; 195, 782–788.
- Augustin M, Zschocke I. Nutsenbewertung der Ambulanten und Stationaeren V.A.C. Therapie aus Pattientensicht. MMW –Forschritte der Medizin Originalien. 2006;1(148):525-32.
- Blume PA, Walters J, Payne W, et al. Comparison of Negative Pressure Wound Therapy Using Vacuum-Assisted Closure With Advanced Moist Wound Therapy in the Treatment of Diabetic Foot Ulcers. Diabetes Care 2008; 31:631–636.
- Vuerstaek JD. State-of-the-art treatment of chronic leg ulcers. A randomized controlled trial comparing vacuum assisted closure (V.A.C.) with modern wound dressings. J Vas Surg. 2006; 44(5):1029-37.
- "Science Behind Wound Therapy". 15 January 2013. Retrieved 15 January 2013.
- ”Kinetic Concepts Inc. Implements SolidWorks Software as Company-Wide Engineering Standard.” Business Wire. 6 March 2000.
- "Kinetic Concepts introduces TriaDyne, latest addition to line of therapeutic beds and surfaces". Business Wire. 23 May 1995.
- Benesh, Peter (14 June 2004). "Second IPO Helps Heal Old Wounds; Kinetic Concepts Inc.; San Antonio, Texas". Investor's Business Daily. p. A09.
- "KCI Honors Dr. Louis Argenta With Research-Based Fellowship and Scholarship". Business Wire. 12 October 2009.
- "KCI earnings up during second quarter". San Antonio Business Journal. 21 July 2009. Retrieved 25 January 2011.
- "KCI to Acquire LifeCell for $1.7 Billion in Cash Creating a Global Medical Technology Leader". Business Wire. 7 April 2008.
- "Analyst questions Kinetic Concepts' purchase of LifeCell due to high price and low revenue". The Associated Press. 8 April 2008.
- Blaker, Ashley (24 December 1990). "Kinetic Expands Foreign Presence With Acquisitions". San Antonio Business Journal 4 (49): 1.
- Berko, Malcolm (3 August 2007). "Wound-care developer is a healthy company". Copley News Service.
- "KCI concludes 2007 on strong note". San Antonio Business Journal. 29 January 2008.
- "Highlights KCI". MSN Money. MSN. January 2011. Retrieved 25 January 2011.
- "Kinetic Concepts 4Q profit grows 12 percent". Bloomberg Business News. Associated Press. 1 February 2011. Retrieved 4 February 2011.
- "KCI to Launch V.A.C.Via, an Advanced Mobile Healing Technology". Business Wire.com. 26 April 2010. Retrieved 25 January 2011.